SARS-CoV-2 is a new strain of Coronavirus that caused the pneumonia outbreak in Wuhan,
China and has spread to over 200 countries of the world. It has received worldwide attention …

Recently, scary viral pneumonia is known as (COVID-19) has swept the whole world. The
new virus strain designated as SARS-CoV-2 belonging to the coronavirus family. Although …

Abstract SARS-CoV-2 papain-like protease is considered as an important potential target for
anti-SARS-CoV-2 drug discovery due to its crucial roles in viral spread and innate immunity …

Abstract Coronavirus disease 2019 (COVID-19) has emerged from China and globally
affected the entire population through the human-to-human transmission of a newly …

Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was
first reported in Wuhan province of China, has become a deadly pandemic causing …

Developing a safe and effective antiviral treatment takes a decade, however, when it comes
to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the …

Background The high transmission and pathogenicity of SARS-CoV-2 has led to a pandemic
that has halted the world's economy and health. The newly evolved strains and scarcity of …

The recent pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection (COVID-19) is a viral respiratory disease that has been spread all over the globe …

Papain-like protease is an essential enzyme in the proteolytic processing required for the
replication of SARS-CoV-2. Accordingly, such an enzyme is an important target for the …

The widespread problem of a 2019-novel coronavirus (SARS-CoV-2) strain outbreak in
Wuhan, China has prompted a search for new drugs to protect against and treat this …